cd38 inhibitor and 5-amino-1mq synergy nad+ CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents Inhibition of CD38 and supplementation
Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide induced microglial and astrocytic neuroinflammation by increasing NAD+ PMC CD38 is a key mediator of NAD+ depletion in the brain of ZIKV infected mice: iScience Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome Small Molecule CD38 Inhibitors: Synthesis of 8 Amino N1 inosine 5 monophosphate, Analogues and Early Structure Activity Relationship Targeting NAD+ Synthesis to Potentiate CD38 Based Immunotherapy of Multiple Myeloma ScienceDirect Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4





